Literature DB >> 10852764

Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes.

J C in 't Veen1, A J Beekman, E H Bel, P J Sterk.   

Abstract

Excessive airway narrowing is a cardinal feature of asthma, and results in closure of airways. Therefore, asthmatic patients in whom airway closure occurs relatively early during expiration might be prone to severe asthma attacks. To test this hypothesis, we compared closing volume (CV) and closing capacity (CC) in a group of asthmatic patients with recurrent exacerbations (more than two exacerbations in the previous year; difficult-to-control asthma), consisting of 11 males and two females, aged 20 to 51 yr, with those in a group of equally severely asthmatic controls without recurrent exacerbations (stable asthma) consisting of 13 males and two females aged 18 to 52 yr. Both groups used equivalent doses of inhaled corticosteroids and were matched for sex, age, atopy, postbronchodilator FEV(1), and provocative concentration of methacholine causing a 20% decrease in FEV(1). They were studied during a clinically stable period of their disease. The patients inhaled 400 microg salbutamol via a spacer device, after which TLC and RV were measured by multibreath helium equilibration, together with the slope of Phase 3 (dN(2)), CV, and CC, by single-breath nitrogen washout. CV and CC were expressed as ratios of VC and TLC, respectively, and all data are presented as % predicted (mean +/- SEM). There was no difference in TLC in patients with difficult-to-control asthma and those with stable asthma (106.7 +/- 4.0% predicted versus 101.7 +/- 4.3% predicted, p = 0.40), RV (113.1 +/- 7.8% predicted versus 100.9 +/- 7.1% predicted, p = 0.26), or dN(2) (142.7 +/- 16.3% predicted versus 116.0 +/- 20.2% predicted, p = 0.23). In contrast, CV and CC were increased in the patients with difficult-to-control asthma as compared with the group with stable asthma (CV: 159.5 +/- 26.8% predicted versus 98.8 +/- 12.5% predicted, p = 0.024; CC: 114.0 +/- 6.4% predicted versus 99.9 +/- 3. 6% predicted, p = 0.030). These findings show that asthmatic individuals with recurrent exacerbations have increased CV and CC as compared with equally severely asthmatic but stable controls, even after bronchodilation during well-controlled episodes. The findings imply that airway closure at relatively high lung volumes under clinically stable conditions might be a risk factor for severe exacerbations in asthmatic patients.

Entities:  

Mesh:

Year:  2000        PMID: 10852764     DOI: 10.1164/ajrccm.161.6.9906075

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  36 in total

1.  Acoustically detectable cellular-level lung injury induced by fluid mechanical stresses in microfluidic airway systems.

Authors:  Dongeun Huh; Hideki Fujioka; Yi-Chung Tung; Nobuyuki Futai; Robert Paine; James B Grotberg; Shuichi Takayama
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

Review 2.  Interleukin-4, interleukin-13, signal transducer and activator of transcription factor 6, and allergic asthma.

Authors:  Douglas A Kuperman; Robert P Schleimer
Journal:  Curr Mol Med       Date:  2008-08       Impact factor: 2.222

Review 3.  Small airways disease in asthma.

Authors:  Jonathan Corren
Journal:  Curr Allergy Asthma Rep       Date:  2008-11       Impact factor: 4.806

Review 4.  What long-term changes in lung function can tell us about asthma control.

Authors:  David A Kaminsky; Charles G Irvin
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

5.  A bioinspired microfluidic model of liquid plug-induced mechanical airway injury.

Authors:  Joseph W Song; Jungwook Paek; Kyu-Tae Park; Jeongyun Seo; Dongeun Huh
Journal:  Biomicrofluidics       Date:  2018-05-29       Impact factor: 2.800

6.  Comparison of two methods of determining lung de-recruitment, using the forced oscillation technique.

Authors:  K Nilsen; K Gove; F Thien; T Wilkinson; B R Thompson
Journal:  Eur J Appl Physiol       Date:  2018-07-30       Impact factor: 3.078

7.  Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations.

Authors:  Eric W Alton; Homer A Boushey; Holger Garn; Francis H Green; Michael Hodges; Richard J Martin; Robert D Murdoch; Harald Renz; Stephen B Shrewsbury; Rosanne Seguin; Graham Johnson; Joel D Parry; Jeff Tepper; Paolo Renzi; Joy Cavagnaro; Nicolay Ferrari
Journal:  Nucleic Acid Ther       Date:  2012-07-18       Impact factor: 5.486

8.  Small airways function and molecular markers in exhaled air in mild asthma.

Authors:  S Battaglia; H den Hertog; M C Timmers; S P G Lazeroms; A M Vignola; K F Rabe; V Bellia; P S Hiemstra; P J Sterk
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration.

Authors:  Kei Shinoda; Yutaka Imamura; Sayaka Matsuda; Maiko Seki; Atsuro Uchida; Terry Grossman; Kazuo Tsubota
Journal:  Open Ophthalmol J       Date:  2008-08-26

10.  Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options.

Authors:  Nicola Scichilone; Adele Contino; Giovanni Battista Figlioli; Giuseppe Paglino; Vincenzo Bellia
Journal:  Patient Prefer Adherence       Date:  2010-02-04       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.